Dexmedetomidine for sedation in procedures outside of surgery rooms Dexmedetomidina para sedación en procedimientos fuera de salas de cirugía

Abstract

Invasive procedures outside surgery rooms can imply significant discomfort for the patient and create technical challenges and deterioration in the quality of care. The above has involved anesthesiologists in the care of these patients outside of surgery rooms. The present prospective study evaluated the use of dexmedetomidine, an a2 agonist authorized as a sedative in the intensive care unit, in 27 patients, between 18 and 80 years of age, with classification of anesthetic risk American Society of Anesthesiology I - IV, who underwent radiology, endoscopy and radiotherapy interventions; Dexmedetomidine is a medication that produces an adequate and safe degree of sedation to perform such interventions outside of surgery rooms. A loading dose of the linfkg drug was administered in 10 minutes, continuing with an infusion between 0.2 and 0.8 pg / kg. The results indicate that the programmed procedures could be carried out in their entirety. There were adverse effects such as hypotension and bradycardia in five cases, which were easy to treat. No patient presented respiratory depression and recovery was rapid with high Aldrete scores. The degree of satisfaction of the patients was, in its great majority, excellent to good. This study suggests the use of dexmedetomidine as a good alternative for anesthetic sedation.